IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Crestline Management, L.P.

Q2 2026 Holdings

Filed 2026-08-14 | 3 holdings | $53.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Denali Therapeutics Inc(DNLI)COM24823R105$49.1M1,910,73291.9%
Sana Biotechnology Inc(SANA)COM799566104$2.6M755,7364.9%
8X8 Inc New(EGHT)COM282914100$1.7M990,8503.2%